Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer Ruby Khatun Khatun3 Sept 2018 5:00 AMMumbai: Pharma major Pfizer fears that the pharma industry is expected to face challenges from price controls, ad-hoc regulatory changes and new...
Glenmark expects generics to drive growth over next 3 yrs Ruby Khatun Khatun25 Sept 2017 5:07 AMMumbai: Pharma firm Glenmark Pharmaceuticals has said its pipeline of specialty and innovative products over the next three to four years is expected...
